• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Sunday 10/21/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

ifosfamide

  • 4:42 PM

    LAGUNA HILLS, Calif., Nov. 29, 2016, PMCB, (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that a Pre-Investigational New Drug (Pre-IND) meeting with the Center for Biologics Evaluation and Research (CBER) of the U.S. Food and Drug Administration (FDA) has been granted by the FDA. During the meeting with representatives from CBER, they will respond to PharmaCyte’s previously

    Read more
  • 2:06 PM

    OTC Markets Group (PublicWire.com Press Release) — NEW YORK, Dec. 2, 2013 /PRNewswire/ — OTC Markets Group Inc. (OTCQX: OTCM) congratulates LiqTech International Inc. (OTCQX: LIQT), an award-winning clean technology company, on its approval to list on the New York Stock Exchange’s NYSE MKT. LiqTech International is moving to the NYSE MKT from OTC Markets Group’s OTCQX® marketplace, making it the seventh company to move from OTCQX to a U.S. stock exchange this year. Since joining OTCQX on February 3,

    Read more
Public Wire Banner